Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Kensington › NPI 1235253485
Physician

International Pediatrics, P a

International Pediatrics, P a was paid $20.96M by Medicaid between Feb 2018 and Dec 2024, across 114 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.

33Billing provider infoINTERNATIONAL PEDIATRICS, P A
KENSINGTON, MD 20895
33aNPI1235253485assigned 03/16/2007
33bProvider typePediatrics Physician
28Total paid$20.96M
24GClaims428,116
24DCodes billed114
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Maryland

Rank by total paid#2 of 306
Median peer was paid$206K
This provider vs. median102×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201863$4K
2019310$10K
202064,809$2.64M
202176,301$3.70M
202298,059$5.29M
2023107,626$5.32M
2024incomplete80,948$3.99M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 32% 77,281 69,355 $6.78M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8.9% 14,458 13,582 $1.87M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6.4% 9,732 9,319 $1.35M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.4% 12,410 12,177 $1.35M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 5.7% 10,995 10,732 $1.19M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 5.2% 9,202 8,935 $1.09M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4.6% 17,493 16,503 $970K
0240U 3.9% 6,118 5,603 $819K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.3% 7,202 6,700 $702K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.7% 5,908 5,589 $576K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2.7% 32,740 31,132 $567K
92552 2.0% 17,223 16,722 $426K
102 more codes
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.6% 10,716 $344K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.6% 6,532 $326K
90686 1.5% 13,976 $315K
90698 <1% 6,512 $143K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 1,127 $131K
99205 Prolong outpt/office vis <1% 600 $117K
90670 <1% 5,246 $115K
92551 <1% 10,473 $99K
90677 <1% 1,285 $86K
D1206 Topical application of fluoride varnish <1% 3,623 $84K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,026 $81K
90680 <1% 3,677 $80K
94760 <1% 30,246 $73K
99173 <1% 28,136 $71K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 491 $69K
90651 <1% 2,873 $68K
90633 <1% 2,922 $66K
0071A <1% 1,425 $56K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,749 $54K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,748 $54K
0072A <1% 1,335 $53K
90744 <1% 2,196 $48K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,781 $42K
96160 <1% 14,003 $38K
99203 Doctor's office visit, new patient (routine) <1% 332 $37K
90619 <1% 1,322 $31K
0001A <1% 785 $30K
90734 <1% 1,216 $28K
0002A <1% 717 $28K
90715 <1% 1,108 $25K
G8417 Bmi is documented above normal parameters and a follow-up plan is documented <1% 2,794 $25K
90661 <1% 760 $22K
90621 <1% 712 $21K
2015F <1% 1,457 $20K
90710 <1% 874 $20K
90696 <1% 857 $20K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,426 $19K
90620 <1% 784 $18K
90716 <1% 723 $16K
81000 <1% 5,660 $16K
3011F <1% 1,734 $16K
99243 <1% 124 $16K
83655 <1% 1,326 $15K
91320 <1% 114 $14K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,075 $14K
96161 <1% 5,445 $14K
90480 <1% 328 $13K
0124A <1% 328 $13K
90707 <1% 555 $12K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 146 $11K
0053A <1% 264 $10K
69210 <1% 198 $8K
90656 <1% 357 $8K
91319 <1% 93 $8K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 398 $8K
99384 <1% 57 $8K
0154A <1% 207 $7K
99383 <1% 58 $7K
85018 <1% 3,202 $7K
85014 <1% 2,907 $6K
0081A <1% 134 $5K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 36 $5K
0073A <1% 144 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 390 $4K
96127 <1% 558 $4K
0082A <1% 96 $4K
0003A <1% 85 $3K
87081 <1% 494 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 142 $3K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 31 $2K
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable <1% 347 $2K
91318 <1% 36 $2K
87634 <1% 43 $2K
84030 <1% 606 $2K
3008F <1% 913 $2K
0004A <1% 46 $2K
97802 <1% 64 $2K
99382 <1% 14 $1K
0052A <1% 24 $880.00
80061 Lipid panel <1% 65 $772.38
A7015 Aerosol mask, used with dme nebulizer <1% 310 $635.93
94664 <1% 62 $574.00
0054A <1% 14 $520.00
36416 <1% 4,837 $508.50
90674 <1% 21 $472.26
0051A <1% 19 $440.00
36415 Collection of venous blood by venipuncture <1% 201 $434.07
83036 Hemoglobin; glycosylated (A1C) <1% 54 $376.65
99080 <1% 28 $320.00
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 330 $269.00
99070 <1% 29 $239.78
99050 <1% 12 $182.26
99051 <1% 19 $160.00
86580 <1% 47 $159.18
86308 <1% 28 $128.32
99000 <1% 1,034 $54.30
82962 <1% 12 $28.72
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 377 $18.24
82948 <1% 12 $12.03
99072 <1% 85 $12.00
91300 <1% 180 $0.26
D0190 0% 234 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialORTEGA, MARIO (PHYSICIAN)